Elsevier Makes Exploration Seamless for Geoscientists - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Elsevier Makes Exploration Seamless for Geoscientists


Elsevier Makes Exploration Seamless for Geoscientists

PR Newswire

NEW YORK, June 25, 2014 /PRNewswire/ --

New plug-in integrates georeferenced maps and scientific data from Geofacets with 2D and 3D geological and geophysical models on Petrel E&P software platform 

Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the launch of Geofacets Connector for Schlumberger Petrel* and Studio*. Geofacets Connector for Petrel and Studio integrates hundreds of thousands of maps and associated papers seamlessly with the Petrel platform's analysis and workflow tools.  

Using Geofacets Connector for Petrel and Studio, geoscientists can query a specific area or topic and, via a single interface, combine georeferenced maps and scientific data from Geofacets with 2D and 3D geological and geophysical models created on the Petrel platform. This integration not only provides a more detailed overview of a region when investigating ways to develop and improve yields, but it also enables users to validate proprietary data with external insights from trusted sources including the Geological Society of America, the Geological Society of London, the Society for Sedimentary Geology and the Society of Economic Geologists. Geoscientists tasked with the discovery and analysis of oil and gas reserves in upstream exploration can therefore make quicker decisions and more confidently assess risks relating to exploration projects.  

"Geofacets Connector for Petrel and Studio enables users to access valuable geologic insights via a single platform," said Ella Balagula, SVP, Engineering and Technology at Elsevier. "The insights added from georeferenced scientific maps play a key role in helping geoscientists understand the potential risks associated with exploring new or frontier areas. No two geoscientists will have the exact same interpretation of a single set of information. Access to Geofacets within the Petrel platform and Studio environment will help to validate and deepen a geoscientist's analyses and interpretations, giving them confidence in their conclusions."

The impact of this technology integration is significant and far reaching, with the potential to improve the efficiency of workflow as well as the effectiveness of research earlier in the exploration process. With seamless access to more tools and resources than ever before - from cutting-edge analysis to growing libraries of geological information - it's never been a more exciting time to be a geoscientist.

The Geofacets Connector for Petrel and Studio is designed to address the evolving ways in which geoscientists work in the 21st century. By seamlessly integrating content and analysis within one platform, Geofacets Connector for Petrel and Studio removes the need to consult multiple sources and tools when performing analysis. Today geoscientists have access to the best of both worlds - content and analysis tools - on a single platform.

The Geofacets Connector for Petrel and Studio will be available from July 10, 2014. For more information, visit http://www.elsevier.com/gfconnector.

# # #

*Mark of Schlumberger

About Geofacets 

Geofacets is a web-based application for geoscientists that combines advanced search features on a map-based interface and trusted scientific maps from peer-reviewed literature, including georeferenced maps that can be integrated into GIS software and presentations. It combines hundreds of thousands of geologic maps from Elsevier and its trusted content partners, with over 70% of maps already georeferenced. Developed for the way geoscientists work today, Geofacets is used by leading companies in natural resource exploration around the world to support and justify business decisions, assess risk in drilling and development activities, and increase exploration team productivity.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell , and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Amy Burnis
Director, Strategic Communications
Elsevier
+1-617-803-8344
a.burnis@elsevier.com

SOURCE Elsevier

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here